Core Scientific Statistics
Total Valuation
Core Scientific has a market cap or net worth of $7.23 billion. The enterprise value is $8.38 billion.
| Market Cap | 7.23B |
| Enterprise Value | 8.38B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Core Scientific has 317.89 million shares outstanding. The number of shares has increased by 15.57% in one year.
| Current Share Class | 317.89M |
| Shares Outstanding | 317.89M |
| Shares Change (YoY) | +15.57% |
| Shares Change (QoQ) | -30.49% |
| Owned by Insiders (%) | 1.94% |
| Owned by Institutions (%) | 106.80% |
| Float | 255.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 1,602.11 |
| PS Ratio | 20.39 |
| Forward PS | 9.85 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 12.62 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 23.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.55
| Current Ratio | 0.55 |
| Quick Ratio | 0.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -82.41 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -4.33% |
| Return on Invested Capital (ROIC) | -16.47% |
| Return on Capital Employed (ROCE) | -76.12% |
| Weighted Average Cost of Capital (WACC) | 26.59% |
| Revenue Per Employee | $1.09M |
| Profits Per Employee | -$3.30M |
| Employee Count | 325 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Core Scientific has paid $978,000 in taxes.
| Income Tax | 978,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +68.64% in the last 52 weeks. The beta is 5.50, so Core Scientific's price volatility has been higher than the market average.
| Beta (5Y) | 5.50 |
| 52-Week Price Change | +68.64% |
| 50-Day Moving Average | 25.37 |
| 200-Day Moving Average | 19.65 |
| Relative Strength Index (RSI) | 45.13 |
| Average Volume (20 Days) | 10,950,015 |
Short Selling Information
The latest short interest is 69.09 million, so 21.74% of the outstanding shares have been sold short.
| Short Interest | 69.09M |
| Short Previous Month | 74.72M |
| Short % of Shares Out | 21.74% |
| Short % of Float | 27.04% |
| Short Ratio (days to cover) | 5.57 |
Income Statement
In the last 12 months, Core Scientific had revenue of $354.74 million and -$1.07 billion in losses. Loss per share was -$3.35.
| Revenue | 354.74M |
| Gross Profit | 76.48M |
| Operating Income | -162.57M |
| Pretax Income | -1.21B |
| Net Income | -1.07B |
| EBITDA | -232.83M |
| EBIT | -310.42M |
| Loss Per Share | -$3.35 |
Balance Sheet
The company has $1.01 billion in cash and $2.16 billion in debt, with a net cash position of -$1.15 billion or -$3.62 per share.
| Cash & Cash Equivalents | 1.01B |
| Total Debt | 2.16B |
| Net Cash | -1.15B |
| Net Cash Per Share | -$3.62 |
| Equity (Book Value) | -1.31B |
| Book Value Per Share | -4.12 |
| Working Capital | -1.21B |
Cash Flow
In the last 12 months, operating cash flow was $573.17 million and capital expenditures -$1.03 billion, giving a free cash flow of -$461.08 million.
| Operating Cash Flow | 573.17M |
| Capital Expenditures | -1.03B |
| Depreciation & Amortization | 65.83M |
| Net Borrowing | 960.57M |
| Free Cash Flow | -461.08M |
| FCF Per Share | -$1.45 |
Margins
| Gross Margin | 21.56% |
| Operating Margin | -45.83% |
| Pretax Margin | -341.40% |
| Profit Margin | n/a |
| EBITDA Margin | -65.64% |
| EBIT Margin | -87.51% |
| FCF Margin | n/a |
Dividends & Yields
Core Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.57% |
| Shareholder Yield | -15.57% |
| Earnings Yield | -14.82% |
| FCF Yield | -6.38% |
Analyst Forecast
The average price target for Core Scientific is $33.36, which is 46.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $33.36 |
| Price Target Difference | 46.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 82.70% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Core Scientific has an Altman Z-Score of -1.96 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.96 |
| Piotroski F-Score | 4 |